HK Stock Market Move | 160 HEALTH(02656) vomits more than 30% before the stock price surged 1.15 times in the previous seven trading days.

160 HEALTH (02656) vomiting over 30%, it is worth noting that the stock has been rising continuously since its debut on March 9, with the stock price rising by 1.15 times in just 7 trading days. The stock price has soared by as much as 11 times in just half a year since listing. As of the time of writing, it has fallen by 30.4% to HK$105.7, with a turnover of HK$1.79 billion. On the news front, on March 11, 160 HEALTH announced the deployment of a "medical digital workforce" system for medical institutions, using an integrated model of "platform + AI intelligence body + operation" to promote the landing application of AI intelligence bodies represented by OpenClaw in medical scenarios. Subsequently, the company disclosed that by December 31, 2025, the group had made positive progress in the digital healthcare solution business. In the fiscal year 2025, the group achieved cooperation with 82 public secondary and above hospitals under the "160AI Hospital" operation, an increase of over 720% year-on-year. In the fourth quarter of 2025, 52 new cooperative public hospitals were added, achieving a growth of 420% month-on-month. In addition, on March 16, 160 HEALTH was originally set to have its IPO lock-up period lifted, but on March 13, the company announced that shareholders voluntarily extended the lock-up period until September 16. On March 17, 160 HEALTH released a profit announcement, expecting to achieve an adjusted net profit ranging from RMB 3 million to 5 million in the fiscal year 2025, compared to an adjusted net loss of RMB 31.5 million in the same period last year. This marks the group's first full-year profit from adjusted net profit.